BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 27038867)

  • 1. [Alzheimer's disease and diabetes - the common pathogenesis].
    Halmos T; Suba I
    Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (Pre)diabetes, brain aging, and cognition.
    S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
    Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease.
    Verdile G; Keane KN; Cruzat VF; Medic S; Sabale M; Rowles J; Wijesekara N; Martins RN; Fraser PE; Newsholme P
    Mediators Inflamm; 2015; 2015():105828. PubMed ID: 26693205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
    Hamzé R; Delangre E; Tolu S; Moreau M; Janel N; Bailbé D; Movassat J
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes drugs in the fight against Alzheimer's disease.
    Boccardi V; Murasecco I; Mecocci P
    Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling.
    Kang S; Kim CH; Jung H; Kim E; Song HT; Lee JE
    Neuropharmacology; 2017 Feb; 113(Pt A):467-479. PubMed ID: 27810390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic literature review of the effect of insulin sensitizers on the cognitive symptoms of Alzheimer's Disease in transgenic mice.
    Craig A; Parvez F; Issberner J
    Behav Brain Res; 2019 Oct; 372():112015. PubMed ID: 31255671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology Associated with Diabetes-induced Tauopathy and Development of Alzheimer's Disease.
    Sarkar P; Banu S; Bhattacharya S; Bala A; Sur D
    Curr Diabetes Rev; 2023; 19(5):e130522204763. PubMed ID: 35570545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?
    Biessels GJ; Kappelle LJ;
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1041-4. PubMed ID: 16246041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities.
    Bednarz K; Siuda J
    Neurol Neurochir Pol; 2021; 55(5):418-428. PubMed ID: 34355790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
    Kimura N
    Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crucial players in Alzheimer's disease and diabetes mellitus: Friends or foes?
    Kubis-Kubiak AM; Rorbach-Dolata A; Piwowar A
    Mech Ageing Dev; 2019 Jul; 181():7-21. PubMed ID: 31085195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: Is Aβ a Crucial Factor in Both Pathologies?
    Campos-Peña V; Toral-Rios D; Becerril-Pérez F; Sánchez-Torres C; Delgado-Namorado Y; Torres-Ossorio E; Franco-Bocanegra D; Carvajal K
    Antioxid Redox Signal; 2017 Apr; 26(10):542-560. PubMed ID: 27368351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
    Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
    Li X; Song D; Leng SX
    Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.